9 reports

Abstract: - Global Neglected Tropical Diseases Diagnosis Market to Reach $7.9 Billion by 2027 - Amid the COVID-19 crisis, the global market for Neglected Tropical Diseases Diagnosis estimated at US$6 Billion in the year 2020, is projected to reach a revised size of US$7.9 Billion by 2027, growing at aCAGR of 4% over...

  • Tropical Disease
  • Diagnostics
  • World
  • China
  • United States

The MEA point of care diagnostics market is expected to grow from US$ 2,484.03 million in 2021 to US$ 5,433.77 million by 2028; it is estimated to grow at a CAGR of 11.8% from 2021 to 2028. Rising number of conferences and events is expected to surge the market growth.Various conferences and events are held to make people aware about...

  • Point Of Care Testing
  • South Africa
  • Saudi Arabia
  • Diabetes Prevalence
  • Laboratory Revenue

The Europe point of care diagnostics market is expected to grow from US$ 8,948.81 million in 2021 to US$ 20,207.60 million by 2028; it is estimated to grow at a CAGR of 12.3% from 2021 to 2028. Rising prevalence of infectious diseases is expected to fuel the market growth.Point-of-care testing (POCT) plays a critical role in diagnosis,...

  • Point Of Care Testing
  • Diagnostics
  • Infectious Disease
  • Europe
  • Drug Approval
  • Laboratory Revenue

The global point of care diagnostics market is expected to reach USD 72.0 billion by 2027 from an estimated USD 43.2 billion in 2022, at a CAGR of 10.8% from 2022 to 2027. Point-of-care testing (POCT) includes screening or diagnostic tests performed outside traditional laboratories. These tests are designed to be used at or near the site where...

  • Point Of Care Testing
  • World
  • North America
  • United States
  • India
  • APAC
  • HIV AIDS Prevalence
  • Chronic Disease Prevalence

The ASEAN and North Asian Point of Care/Rapid Diagnostics market size is expected to grow from an estimated USD 2.0 billion in 2021 to USD 3.9 billion by 2026, at a CAGR of 13.0%. The growing demand for accurate and early diagnostic methodologies, modernization and expansion of healthcare infrastructure and significant disease prevalence are...

  • Diagnostics
  • Asia
  • ASEAN
  • Health Expenditure
  • Gross Domestic Expenditure On R&D

Abstract: What`s New for 2022? -Global competitiveness and key competitor percentage market shares -Market presence across multiple geographies - Strong/Active/Niche/Trivial -Online interactive peer-to-peer collaborative bespoke updates -Access to our digital archives and MarketGlass...

  • Molecular Diagnostics
  • World
  • APAC
  • Europe

The global plant-based vaccines market is expected to reach US$ 2,672.05 million by 2028 from US$ 1,143.72 million in 2021, growing at a CAGR of 12.9 % from 2021 to 2028. Increasing research & development (R & R&D) activities and the growing prevalence of infectious diseases are fueling the market’s growth. However, the potential risk of...

  • Infectious Disease
  • Vaccine
  • World
  • APAC
  • Middle East
  • Health Expenditure
  • Mortality Rate

Summary NOWDiagnostics Inc (NOWDiagnostics) is a medical diagnostic company.The company manufactures and sells blood-based rapid tests. The company offers COVID-19 test, acetaminophen test, hCG test, H-FABP test, methanol dip test, salicylate test, troponin I test, myoglobin test, in home HIV test, and others.NOWDiagnostics’...

  • Diagnostics
  • Clinical Trial
  • World
  • Europe
  • Italy
  • Medical Devices Sales

Summary Mologic Ltd (Mologic) is a medical device company that designs, develops, manufactures and supplies in vitro diagnostic medical devices.The portfolio of companys products include bacterial vaginosis test kit, peritoneal dialysis test, lateral flow kit, desmosine ELISA kit and FMLP ELISA kit. It offers expertise...

  • Infectious Disease
  • Diagnostics
  • Clinical Trial
  • United Kingdom
  • Senegal
  • United States
  • West Africa
  • Hospital Admission
  • Medical Devices Sales